Investigating the possible therapeutic effects of the homoeopathic remedy Apis Mellifica on Weaver Fish stings using a double blind randomised controlled trial
| ISRCTN | ISRCTN16880978 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN16880978 |
| Protocol serial number | 2005-005934-11 |
| Sponsor | Cornwall College Camborne (UK) |
| Funders | Cornwall College Camborne (UK), Royal National Lifeboat Institution (UK) |
- Submission date
- 21/12/2005
- Registration date
- 21/12/2005
- Last edited
- 06/09/2016
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Injury, Occupational Diseases, Poisoning
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Mr David Retford
Scientific
Scientific
Opie Building
Trevenson Road
Pool, Redruth
TR15 3RD
United Kingdom
| Phone | +44 (0)1209 617620 |
|---|---|
| david.retford@cbs.ac.uk |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Double Blind Randomised Controlled Trial (RCT) |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | Investigating the possible Therapeutic Effects of the Homoeopathic Remedy Apis Mellifica on Weaver Fish Stings using a Double Blind Randomised Controlled Trial |
| Study acronym | Weaver-fish & Homoeopathy |
| Study objectives | That homoeopathic apis mellificia will be more effective in treating the sting from a weaver fish than a placebo |
| Ethics approval(s) | Informed consent: understanding spoken and written english, over the age of eighteen, or with parental guidance and consent if under 18. There will be written informed consent from all participants or parents where needed. Informed of data protection, and possible adverse reactions to the homoeopathic remedy. Openness and honesty: Double blind test, thus the participant might be given a placebo although they will still receive the standard treatment. Right to withdraw. Protection from possible harm. Debriefing. Confidentiality and to follow all ethical principals of relevent professional bodies. |
| Health condition(s) or problem(s) studied | Sting from weaver fish |
| Intervention | Standard treatment of feet submerged in hot water, plus homoeopathic remedy or placebo remedy |
| Intervention type | Drug |
| Phase | Not Specified |
| Drug / device / biological / vaccine name(s) | Apis Mellifica |
| Primary outcome measure(s) |
Pain relief |
| Key secondary outcome measure(s) |
Removal of concomitant symptoms |
| Completion date | 31/10/2006 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | All |
| Target sample size at registration | 250 |
| Key inclusion criteria | Type 1, healthy clients, affected by weaver-fish sting, within one hour. |
| Key exclusion criteria | 1. Over 65 years of age 2. Unable to read english 3. Taking any prescribed medication 4. Not NHS registered 5. Have taken any previous form of treatment for the sting 6. Have been stung already this year 7. Any heart condition 8. Any other contraindications to treatment |
| Date of first enrolment | 01/03/2006 |
| Date of final enrolment | 31/10/2006 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
Opie Building
Pool, Redruth
TR15 3RD
United Kingdom
TR15 3RD
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
| Study website | Study website | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
06/09/2016: No publications found in PubMed, verifying study status with principal investigator.